Dr Reddy’s Lab has tied up with Russian manufacturer Russian Direct Investment Fund (RDIF) to sell 10 million vaccines of Corona in India. Corona vaccine will arrive in India by November. After this news came, Dr Reddy’s stock on BSE reached 4624.45 with a strength of Rs 181.
According to the news, RDIF has launched Dr Sputnik V vaccine in Russia for clinical trials and distribution in India. Reddy’s Laboratories is compromised. As per the agreement Russian company in India Will supply 100 million vaccines to Reddy’s.
Corona vaccine will arrive in India by November
RDIF CEO Kirill Dimitriv said in a statement that the vaccine will be available in India by November if the trial is successful.
He said that Dr. Reddy’s has a business presence in Russia for almost 25 years and is a major Indian company.
He claimed that the Russian vaccine based on the Human Adenovirus Dual Vector platform would help in the safe fight against covid-19 in India. He said that about 250 clinical trials of human adenovirus dual vector platform have been done in Russia in the last decade and no possible negative results have been seen.
Phase 3 will be tested in India
Dr. GV Prasad, managing director of Reddy’s said, “Phase 1 and Phase 2 testing of this vaccine has been successful and now we will test its third phase in India, so that the necessary regulatory conditions are met.”
Significantly, the first corona vaccine in the world was launched on August 11 in Russia, named Sputnik Vaccine. This vaccine was tested only in Phase 1 and Phase 2.